DGX vs MRBK · P/E 22, rev $5.94B vs P/E 11, rev $3.4M
Quest Diagnostics Incorporated (DGX) versus Meridian Bank (MRBK) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Meridian Bank (MRBK) is a banks - regional company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported MRBK revenue for 2026-06-30 was $3.4M. Net income was $7.8M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MRBK currently screens at market cap $236.3M and trailing P/E 10.7.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. MRBK currently screens at market cap $236.3M and trailing P/E 10.7.
Not investment advice. Open the DGX and MRBK stock pages for the full models.
Not investment advice.